carbamates has been researched along with Anxiety in 68 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine." | 7.91 | Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019) |
" In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated." | 7.74 | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008) |
"Our results reveal that experimentally increasing anandamide levels in female prairie voles can increase social contact with both a familiar and novel male via unknown mechanisms that are likely separate from anxiety reduction." | 4.02 | Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster). ( Bales, KL; Simmons, TC; Singh, ALK, 2021) |
"This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice." | 4.02 | URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels. ( Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR, 2021) |
"We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine." | 3.91 | Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019) |
" Exposure to phenobarbital during this period has been associated with deficits in learning and memory, anxiety-like behavior, and social behavior, among other domains." | 3.83 | Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats. ( Forcelli, PA; Frankel, S; Gutherz, S; Kondratyev, A; Kulick, C; Medvedeva, N, 2016) |
" Here, we investigated whether prenatal stress--in the form of gestational exposure to corticosterone supplemented in the maternal drinking water (100 mg/l) during the last week of pregnancy--combined with a pharmacological stimulation of the ECS during adolescence (daily fatty acid amide hydrolase URB597 i." | 3.78 | Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice. ( Canese, R; Ceci, C; Laviola, G; Macrì, S, 2012) |
"In the present study we explored with a multidisciplinary approach, the role of anandamide (AEA) in the modulation of anxiety behavior at the level of the prefrontal cortex (PFC)." | 3.74 | Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. ( Castiglioni, C; Di Marzo, V; Guidali, C; Maccarrone, M; Marras, E; Parolaro, D; Perletti, G; Petrosino, S; Realini, N; Rubino, T; Viganó, D, 2008) |
" In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated." | 3.74 | Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008) |
"We hypothesized that restless legs syndrome (RLS), a common neurological sensorimotor disorder of uncomfortable leg sensations that appear at night and interfere with sleep, might be a cause for nighttime agitation in persons with AD." | 2.94 | Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest). ( Allen, R; Fry, L; Gooneratne, N; Hanlon, A; Kovach, C; Loera, A; Lozano, A; Morrison, J; Rangel, A; Richards, K; Wang, YY, 2020) |
"Similar to clinical PTSD, approximately 25-30% of rats that undergo cued fear conditioning exhibit impaired extinction learning." | 1.56 | Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. ( Diwan, M; Giacobbe, P; Gidyk, DC; Gouveia, FV; Hamani, C; Lipsman, N; Nobrega, JN; Vimalanathan, A, 2020) |
"Treatment with diazepam (1 mg/kg) increased tolerance without affecting avoidance behavior in HAB mice." | 1.46 | Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle. ( Genewsky, A; Heinz, DE; Wotjak, CT, 2017) |
"Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184." | 1.42 | Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. ( Bindila, L; Hoheisel, U; Lerner, R; Lomazzo, E; Lutz, B; Remmers, F; Schwitter, C, 2015) |
"Status epilepticus was induced by administration of KA either intraperitoneally (15 mg/kg) or by single intrahippocampal injection (1." | 1.40 | Retigabine calms seizure-induced behavior following status epilepticus. ( Ali, SS; Friedman, LK; Naseer, Z; Slomko, AM; Wongvravit, JP, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (41.18) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (17.65) | 29.6817 |
2010's | 22 (32.35) | 24.3611 |
2020's | 6 (8.82) | 2.80 |
Authors | Studies |
---|---|
da Motta, KP | 1 |
Santos, BF | 1 |
Domingues, NLC | 1 |
Luchese, C | 1 |
Wilhelm, EA | 1 |
Vimalanathan, A | 1 |
Gidyk, DC | 1 |
Diwan, M | 1 |
Gouveia, FV | 1 |
Lipsman, N | 1 |
Giacobbe, P | 1 |
Nobrega, JN | 1 |
Hamani, C | 1 |
Ferizovic, H | 1 |
Spasojevic, N | 1 |
Stefanovic, B | 1 |
Jankovic, M | 1 |
Dronjak, S | 1 |
Richards, K | 1 |
Morrison, J | 1 |
Wang, YY | 1 |
Rangel, A | 1 |
Loera, A | 1 |
Hanlon, A | 1 |
Lozano, A | 1 |
Kovach, C | 1 |
Gooneratne, N | 1 |
Fry, L | 1 |
Allen, R | 1 |
Simmons, TC | 1 |
Singh, ALK | 1 |
Bales, KL | 1 |
Ebrahimi-Ghiri, M | 1 |
Khakpai, F | 1 |
Zarrindast, MR | 1 |
Aisenberg, N | 1 |
Serova, L | 1 |
Sabban, EL | 1 |
Akirav, I | 1 |
Seillier, A | 2 |
Giuffrida, A | 2 |
Heinz, DE | 1 |
Genewsky, A | 1 |
Wotjak, CT | 1 |
Flannery, LE | 1 |
Kerr, DM | 1 |
Finn, DP | 1 |
Roche, M | 1 |
Nawata, Y | 1 |
Yamaguchi, T | 1 |
Fukumori, R | 1 |
Yamamoto, T | 1 |
Hartmann, A | 1 |
Fassini, A | 2 |
Scopinho, A | 1 |
Correa, FM | 1 |
Guimarães, FS | 2 |
Lisboa, SF | 2 |
Resstel, LB | 3 |
Banji, D | 1 |
Banji, OJ | 1 |
Ragini, M | 1 |
Annamalai, AR | 1 |
Slomko, AM | 1 |
Naseer, Z | 1 |
Ali, SS | 1 |
Wongvravit, JP | 1 |
Friedman, LK | 1 |
Lomazzo, E | 1 |
Bindila, L | 1 |
Remmers, F | 1 |
Lerner, R | 1 |
Schwitter, C | 1 |
Hoheisel, U | 1 |
Lutz, B | 2 |
Viana, TG | 1 |
Hott, SC | 1 |
Aguiar, DC | 1 |
Moreira, FA | 2 |
Borges, AA | 1 |
Nejo, P | 1 |
Manduca, A | 1 |
Morena, M | 2 |
Campolongo, P | 2 |
Servadio, M | 1 |
Palmery, M | 1 |
Trabace, L | 1 |
Hill, MN | 2 |
Vanderschuren, LJ | 1 |
Cuomo, V | 1 |
Trezza, V | 1 |
Qin, M | 1 |
Zeidler, Z | 1 |
Moulton, K | 1 |
Krych, L | 1 |
Xia, Z | 1 |
Smith, CB | 1 |
Carnevali, L | 1 |
Vacondio, F | 1 |
Rossi, S | 1 |
Macchi, E | 1 |
Spadoni, G | 1 |
Bedini, A | 1 |
Neumann, ID | 1 |
Rivara, S | 1 |
Mor, M | 2 |
Sgoifo, A | 1 |
Aliczki, M | 1 |
Barna, I | 2 |
Till, I | 1 |
Baranyi, M | 1 |
Sperlagh, B | 1 |
Goldberg, SR | 2 |
Haller, J | 3 |
Frankel, S | 1 |
Medvedeva, N | 1 |
Gutherz, S | 1 |
Kulick, C | 1 |
Kondratyev, A | 1 |
Forcelli, PA | 1 |
Leitl, KD | 1 |
Vecchiarelli, HA | 1 |
Gray, JM | 1 |
Micale, V | 1 |
Cristino, L | 1 |
Tamburella, A | 1 |
Petrosino, S | 2 |
Leggio, GM | 1 |
Drago, F | 1 |
Di Marzo, V | 2 |
Barsvari, B | 1 |
Gyimesi Pelczer, K | 1 |
Yasar, S | 2 |
Panlilio, LV | 1 |
Goldberg, S | 1 |
Roohbakhsh, A | 1 |
Keshavarz, S | 1 |
Hasanein, P | 1 |
Rezvani, ME | 1 |
Moghaddam, AH | 1 |
Cippitelli, A | 2 |
Astarita, G | 1 |
Duranti, A | 3 |
Caprioli, G | 1 |
Ubaldi, M | 1 |
Stopponi, S | 1 |
Kallupi, M | 1 |
Sagratini, G | 1 |
Rodrìguez de Fonseca, F | 1 |
Piomelli, D | 4 |
Ciccocioppo, R | 2 |
Zaitone, SA | 1 |
El-Wakeil, AF | 1 |
Abou-El-Ela, SH | 1 |
Macrì, S | 1 |
Ceci, C | 1 |
Canese, R | 1 |
Laviola, G | 1 |
Khatri, M | 1 |
Rai, SK | 1 |
Ranbhor, R | 1 |
Kishore, K | 1 |
Tiwari, M | 1 |
HALPERN, BN | 1 |
LEHMANN, A | 1 |
GILLHESPY, RO | 1 |
CAHN, B | 1 |
DARBELLAY, J | 1 |
HSU, JJ | 1 |
BRAUN, RA | 1 |
DOMINO, EF | 1 |
LOWINGER, P | 1 |
SCHORER, C | 1 |
BRUCK, M | 1 |
CAUSSE, R | 1 |
TOFFOL, DE | 1 |
D AMELIO, V | 1 |
ANNOVI, G | 1 |
RAAB, E | 1 |
RICKELS, K | 1 |
MOORE, E | 1 |
GREENWALD, AS | 1 |
SEEHERMAN, R | 1 |
GANTT, WH | 1 |
BUTTON, JT | 1 |
COLE, WV | 1 |
CHESROW, EJ | 1 |
KAPLITZ, SE | 1 |
SABATINI, R | 1 |
VETRA, H | 1 |
MARQUARDT, GH | 1 |
Korsgaard, MP | 1 |
Hartz, BP | 1 |
Brown, WD | 1 |
Ahring, PK | 1 |
Strøbaek, D | 1 |
Mirza, NR | 2 |
Blackburn-Munro, G | 1 |
Dalby-Brown, W | 1 |
Mikkelsen, JD | 1 |
Blackburn-Munro, RE | 1 |
Tarzia, G | 1 |
Tontini, A | 2 |
Compton, TR | 1 |
Dasse, O | 1 |
Monaghan, EP | 1 |
Parrott, JA | 1 |
Putman, D | 1 |
Naidu, PS | 1 |
Varvel, SA | 1 |
Ahn, K | 1 |
Cravatt, BF | 1 |
Martin, BR | 1 |
Lichtman, AH | 1 |
Kaiser, N | 1 |
Monory, K | 1 |
Scherma, M | 1 |
Medalie, J | 1 |
Fratta, W | 1 |
Vadivel, SK | 1 |
Makriyannis, A | 1 |
Mikics, E | 1 |
Tanda, G | 1 |
Rubino, T | 1 |
Realini, N | 1 |
Castiglioni, C | 1 |
Guidali, C | 1 |
Viganó, D | 1 |
Marras, E | 1 |
Perletti, G | 1 |
Maccarrone, M | 1 |
Parolaro, D | 1 |
Naderi, N | 1 |
Haghparast, A | 1 |
Saber-Tehrani, A | 1 |
Rezaii, N | 1 |
Alizadeh, AM | 1 |
Khani, A | 1 |
Motamedi, F | 1 |
Cannella, N | 1 |
Braconi, S | 1 |
Bilbao, A | 1 |
Defonseca, FR | 1 |
Spry, WB | 1 |
Linford Rees, W | 1 |
Guthy, H | 1 |
Kissin, B | 1 |
Gross, MM | 1 |
DiMascio, A | 2 |
Gardos, G | 1 |
Harmatz, J | 1 |
Shader, R | 1 |
Shader, RI | 1 |
Harmatz, JS | 1 |
Lehmann, HE | 1 |
Ban, TA | 1 |
Bratfos, O | 1 |
Lingjaerde, O | 1 |
Salvesen, C | 1 |
Cremoncini, C | 1 |
Liuzzi, A | 1 |
Perez de Francisco, C | 1 |
Meshel, E | 1 |
Denber, HC | 1 |
Solaro, F | 1 |
Corletto, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease[NCT03082755] | Phase 4 | 156 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for carbamates and Anxiety
Article | Year |
---|---|
Retigabine: chemical synthesis to clinical application.
Topics: Animals; Anticonvulsants; Anxiety; Carbamates; Dose-Response Relationship, Drug; Epilepsy; Humans; K | 2005 |
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
Topics: Amidohydrolases; Analgesics; Animals; Anxiety; Benzamides; Brain; Cannabinoids; Carbamates; Depressi | 2006 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
7 trials available for carbamates and Anxiety
Article | Year |
---|---|
Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest).
Topics: Aged; Alzheimer Disease; Anxiety; Carbamates; Double-Blind Method; Female; gamma-Aminobutyric Acid; | 2020 |
Tybamate: an examination of its actions in "high" and "low" anxious normals.
Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Cognition; E | 1969 |
Single versus repeated dosage of the minor tranquilizer chlordiazepoxide (Librium).
Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Evaluation S | 1972 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
Symptomatic relief of neurotic symptoms with tybamate: a doube-blind, placebo-controlled study.
Topics: Adult; Aged; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; Hysteria; Ma | 1967 |
Serax and solacen.
Topics: Aged; Antidepressive Agents; Anxiety; Carbamates; Clinical Trials as Topic; Humans; Hyperventilation | 1965 |
Double-blind study of tybamate in psychotic patients.
Topics: Adult; Aged; Aggression; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; | 1967 |
59 other studies available for carbamates and Anxiety
Article | Year |
---|---|
Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy.
Topics: Adenosine Triphosphatases; Analgesics; Animals; Anxiety; Benzoates; Carbamates; Cerebral Cortex; Cho | 2022 |
Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Topics: Animals; Anxiety; Benzamides; Benzoxazines; Carbamates; Conditioning, Psychological; Disease Models, | 2020 |
The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Catechol O-Methyltra | 2020 |
Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster).
Topics: Animals; Anxiety; Arachidonic Acids; Arvicolinae; Behavior, Animal; Benzamides; Carbamates; Endocann | 2021 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; C | 2021 |
The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
Topics: Amidohydrolases; Animals; Anxiety; Basolateral Nuclear Complex; Benzamides; CA1 Region, Hippocampal; | 2017 |
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Cannabinoids; Carbamates | 2017 |
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Avoidance Learning; Behav | 2017 |
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats.
Topics: Amidohydrolases; Animals; Anxiety; Benzamides; Carbamates; Central Nervous System Agents; Enzyme Inh | 2018 |
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Add | 2019 |
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Arterial Pressure; Behavior, Animal; Benzamide | 2019 |
Carbosulfan exposure during embryonic period can cause developmental disability in rats.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Brain; Carbamates; Embry | 2014 |
Retigabine calms seizure-induced behavior following status epilepticus.
Topics: Animals; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Convulsants; Hippocampus; Hyperkine | 2014 |
Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
Topics: Amidohydrolases; Analgesics, Non-Narcotic; Animals; Anxiety; Benzamides; Benzodioxoles; Brain; Carba | 2015 |
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Dise | 2015 |
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence.
Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Drinking; Drink | 2015 |
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Topics: Aging; Animals; Anxiety; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Carbamates; Endo | 2015 |
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Avoidance Learning; Benzamides; Cannabinoid Re | 2015 |
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arrhythmias, Cardiac; Behavior, Animal; Biph | 2015 |
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.
Topics: Adaptation, Psychological; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Basolateral Nuc | 2016 |
Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.
Topics: Animals; Animals, Newborn; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Cognition; Dose-R | 2016 |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety.
Topics: Animals; Anxiety; Arachidonic Acids; Arousal; Basolateral Nuclear Complex; Benzamides; Cannabinoid R | 2016 |
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Topics: Amidohydrolases; Anilides; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides; Bra | 2009 |
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Chlordiazepoxide; Di | 2009 |
Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
Topics: Amidohydrolases; Animals; Anxiety; Baclofen; Behavior, Animal; Benzamides; Bicuculline; Cannabinoid | 2009 |
Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzamides; Carbamates; En | 2011 |
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid | 2011 |
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Topics: Acetaminophen; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides | 2012 |
Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice.
Topics: Anhedonia; Animals; Anxiety; Benzamides; Body Weight; Brain; Carbamates; Corticosterone; Drinking; E | 2012 |
Synthesis and pharmacological evaluation of [(4-arylpiperazin-1-yl)-alkyl]-carbamic acid ethyl ester derivatives as potential anxiolytic agents.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbamates; Cerebral Cortex; Computer-Aided | 2012 |
[Experimental bases of the therapeutic action of a new sedative and anti-anxious preparation: 3-methyl-1-pentyne-3-o1 carbamate].
Topics: Anxiety; Carbamates; Humans; Hypnotics and Sedatives; Tranquilizing Agents | 1957 |
Methylpentynol carbamate in the management of insomnia and parkinsonism.
Topics: Anxiety; Carbamates; Humans; Parkinson Disease; Parkinsonian Disorders; Sleep Initiation and Mainten | 1958 |
Effect of hydroxyphenamate in the treatment of mild and moderate anxiety states. (A double blind study with crossover pattern).
Topics: Anxiety; Butylene Glycols; Carbamates; Double-Blind Method; Tranquilizing Agents | 1961 |
[THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE].
Topics: Alcoholism; Anxiety; Anxiety Disorders; Automobiles; Carbamates; Cats; Depression; Geriatrics; Mice; | 1963 |
CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS.
Topics: Anxiety; Brain; Brain Damage, Chronic; Butylene Glycols; Carbamates; Humans; Mental Disorders; Psych | 1963 |
[VALUE OF 1-CYCLOHEXYLPROPYL CARBAMATE IN NEURO-PSYCHIATRY].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Carbamates; Humans; Neurolog | 1963 |
[TREATMENT WITH MEBUTAMATE (AN ANTIHYPERTENSIVE WITH CENTRAL ACTION) OF MENTAL PATIENTS WITH HYPERTENSIVE MANIFESTATIONS].
Topics: Alcoholism; Antihypertensive Agents; Anxiety; Bipolar Disorder; Carbamates; Dementia; Epilepsy; Huma | 1963 |
A DOUBLE-BLIND EVALUATION OF TYBAMATE IN ANXIOUS NEUROTIC MEDICAL CLINIC PATIENTS.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Black People; Carbamates; Double-Blind Method; Huma | 1964 |
RELIEF OF TENSION IN DENTAL PATIENTS: A CONTROLLED STUDY WITH HYDROXYPHENAMATE.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Butylene Glycols; Carbamates; Dentistry; Pharmacolo | 1964 |
EVALUATION OF TYBAMATE IN THE CLINICAL MANAGEMENT OF ANXIETY.
Topics: Anxiety; Biomedical Research; Carbamates; Placebos; Toxicology; Tranquilizing Agents | 1964 |
THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. EXPERIMENTAL STUDIES IN ANIMALS OF THE EFFECTS OF DRUGS ON CARDIAC STRESS SYMPTOMS.
Topics: Animals; Anxiety; Blood Pressure; Carbamates; Conditioning, Classical; Dogs; Electrocardiography; He | 1964 |
TREATMENT OF EMOTIONAL DISTURBANCES IN CLINIC PATIENTS.
Topics: Adolescent; Affective Symptoms; Anxiety; Anxiety Disorders; Biomedical Research; Carbamates; Drug Th | 1965 |
A NEW PSYCHOTHERAPEUTIC AGENT EFFECTIVE IN THE MANAGEMENT OF GERIATRIC ANXIETY, DEPRESSION AND BEHAVIORAL REACTIONS.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Brain; Brain Damage, Chronic; Carbamates; Depressio | 1965 |
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line; | 2005 |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Cannabinoid Rece | 2007 |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Topics: Amidohydrolases; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzam | 2008 |
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
Topics: Amidohydrolases; Analgesics; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Avoidance Le | 2008 |
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Dose-R | 2008 |
Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Benzoxazines; Ca | 2008 |
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
Topics: Adrenergic alpha-Antagonists; Alcohol Drinking; Alcoholism; Amidohydrolases; Animals; Anxiety; Arach | 2008 |
Tybamate.
Topics: Anxiety; Carbamates; Depression; Humans; Tranquilizing Agents | 1967 |
Tybamate: a new tranquillizer.
Topics: Adolescent; Adult; Anxiety; Carbamates; Depression; Female; Humans; Male; Middle Aged; Tranquilizing | 1967 |
The treatment of anxiety states by drugs and other means.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety; Barbit | 1979 |
[The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)].
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Carbamates; Chemical Phenomena; Ch | 1975 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
[Tybamate, recently synthetized anxiolytic agent, in the treatment of emotional and neurovegetative symptoms of hyperthyroidism. Clinico-statistical study].
Topics: Adolescent; Adult; Affective Symptoms; Aged; Animals; Anxiety; Autonomic Nervous System; Carbamates; | 1972 |
[Psychopharmacological treatment of anxiety].
Topics: Adult; Amitriptyline; Anxiety; Benzazepines; Carbamates; Chlordiazepoxide; Diazepam; Dibenzazepines; | 1971 |
[Tybamate in the practice at geriatric outpatient clinics].
Topics: Aged; Anxiety; Brain Damage, Chronic; Carbamates; Depression; Female; Humans; Male; Middle Aged; Out | 1968 |
Evaluation of a new minor tranquilizer: tybamate (Solacen).
Topics: Anxiety; Carbamates; Humans; Tranquilizing Agents | 1965 |